 |
Top 78 Diabetes treatment startups
Oct 12, 2024 | By Jason Kwon | 23 |
These startups develop new diabetes management and treatment technologies such as continuous glucose monitoring, insulin pumps, artificial pancreas systems, smart insulin pens, diabetes management apps.
1
Country: USA | Funding: $3.2M
MelliCell develops therapeutics for diabetes and obesity using a proprietary in vitro model of weight gain in human fat cells.
MelliCell develops therapeutics for diabetes and obesity using a proprietary in vitro model of weight gain in human fat cells.
2
Country: USA | Funding: $301M
Glooko delivers a unified platform for diabetes management. We strive to improve health outcomes for people with diabetes and reduce the costs associated with diabetes population management. Glooko is dedicated to bringing innovation to diabetes management around the world.
Glooko delivers a unified platform for diabetes management. We strive to improve health outcomes for people with diabetes and reduce the costs associated with diabetes population management. Glooko is dedicated to bringing innovation to diabetes management around the world.
3
Country: USA | Funding: $3.5B
We are developing tools and platforms to enable more continuous health data collection for timely decision-making and effective interventions. We are running longitudinal studies to better understand ways to predict and prevent disease onset and progression. And, we are undertaking significant joint efforts with partners to radically transform the way healthcare is delivered.
We are developing tools and platforms to enable more continuous health data collection for timely decision-making and effective interventions. We are running longitudinal studies to better understand ways to predict and prevent disease onset and progression. And, we are undertaking significant joint efforts with partners to radically transform the way healthcare is delivered.
4
Country: Ukraine | Funding: $658.9M
Noom's fully-mobile programs prevent/manage/reverse chronic and pre-chronic conditions such as obesity, diabetes and hypertension.
Noom's fully-mobile programs prevent/manage/reverse chronic and pre-chronic conditions such as obesity, diabetes and hypertension.
5
Country: USA | Funding: $550.5M
Senseonics designed the first and only CGM with an implantable sensor that lasts up to 90 days.
Senseonics designed the first and only CGM with an implantable sensor that lasts up to 90 days.
6
Country: USA | Funding: $544.8M
Carmot Therapeutics provides drugs to treat inflammatory, metabolic, and neurological diseases.
Carmot Therapeutics provides drugs to treat inflammatory, metabolic, and neurological diseases.
7
Country: USA | Funding: $528.5M
A digital behavioral medicine company dedicated to inspiring and empowering people everywhere to live free of chronic illiness.
A digital behavioral medicine company dedicated to inspiring and empowering people everywhere to live free of chronic illiness.
8
Country: USA | Funding: $498.5M
Provention Bio is a clinical stage biopharmaceutical dedicated to sourcing, developing and commercializing novel therapeutics.
Provention Bio is a clinical stage biopharmaceutical dedicated to sourcing, developing and commercializing novel therapeutics.
9
Country: USA | Funding: $373M
Virta is the first clinically-proven treatment to safely and sustainably reverse type 2 diabetes without medications or surgery.
Virta is the first clinically-proven treatment to safely and sustainably reverse type 2 diabetes without medications or surgery.
10
Country: USA | Funding: $293.5M
Beta Bionics is the first medical device company to be doing business as a benefit corporation, and we’re fairly certain that Beta Bionics is the first company to do so in the diabetes space. It develops iLet - a fully integrated bionic pancreas.
Beta Bionics is the first medical device company to be doing business as a benefit corporation, and we’re fairly certain that Beta Bionics is the first company to do so in the diabetes space. It develops iLet - a fully integrated bionic pancreas.
11
Country: USA | Funding: $255.7M
DarioHealth is a digital therapeutics company engaged in the development and commercialization of patented and proprietary technology.
DarioHealth is a digital therapeutics company engaged in the development and commercialization of patented and proprietary technology.
12
Country: USA | Funding: $254.3M
Biolinq develops skin-applied electronic sensors. Finally, people with diabetes will have a better CGM experience that is not only more affordable, but also pain-free.
Biolinq develops skin-applied electronic sensors. Finally, people with diabetes will have a better CGM experience that is not only more affordable, but also pain-free.
13
Country: USA | Funding: $248.5M
Twin Health is a Precision Health platform combining IoT Sensors, Machine Learning, and Medical Science to improve human metabolic health.
Twin Health is a Precision Health platform combining IoT Sensors, Machine Learning, and Medical Science to improve human metabolic health.
14
Country: USA | Funding: $248.2M
Empowering All People with Chronic Conditions to Live Better and Healthier Lives. Livongo. We create personalized experiences, using data and clinical science that deliver positive health outcomes, lower costs, and help members thrive.
Empowering All People with Chronic Conditions to Live Better and Healthier Lives. Livongo. We create personalized experiences, using data and clinical science that deliver positive health outcomes, lower costs, and help members thrive.
15
Country: USA | Funding: $235.5M
ViaCyte is a leader in the emerging field of regenerative medicine. ViaCyte's innovative product is based on the differentiation of stem cells into pancreatic beta cell precursors, with subcutaneous implantation in a retrievable and immune-protective encapsulation medical device. Once implanted, the precursor cells mature into endocrine cells that secrete insulin and other hormones in a regulated manner to control blood glucose levels. ViaCyte's goal is a product that can free patients with type 1 and type 2 diabetes from long-term insulin dependence.
ViaCyte is a leader in the emerging field of regenerative medicine. ViaCyte's innovative product is based on the differentiation of stem cells into pancreatic beta cell precursors, with subcutaneous implantation in a retrievable and immune-protective encapsulation medical device. Once implanted, the precursor cells mature into endocrine cells that secrete insulin and other hormones in a regulated manner to control blood glucose levels. ViaCyte's goal is a product that can free patients with type 1 and type 2 diabetes from long-term insulin dependence.
16
Country: USA | Funding: $204.6M
Bigfoot Biomedical is dedicated to designing simpler, safer, and more effective insulin delivery system for people with insulin-dependent diabetes.
Bigfoot Biomedical is dedicated to designing simpler, safer, and more effective insulin delivery system for people with insulin-dependent diabetes.
17
Country: USA | Funding: $195.7M
Lark Health develops AI-based chronic disease management platform for diabetes, hyper tension and behavioral health.
Lark Health develops AI-based chronic disease management platform for diabetes, hyper tension and behavioral health.
18
Country: USA | Funding: $185M
Insulet Corporation is an innovative medical device company dedicated to making the lives of people with diabetes easier. Through its OmniPod Insulin Management System, Insulet seeks to expand the use of insulin pump therapy among people with insulin-dependent diabetes. The OmniPod is a revolutionary and easy-to-use tubeless insulin pump that features just two parts and a fully-automated cannula insertion.
Insulet Corporation is an innovative medical device company dedicated to making the lives of people with diabetes easier. Through its OmniPod Insulin Management System, Insulet seeks to expand the use of insulin pump therapy among people with insulin-dependent diabetes. The OmniPod is a revolutionary and easy-to-use tubeless insulin pump that features just two parts and a fully-automated cannula insertion.
19
Country: USA | Funding: $163M
Semma Therapeutics was founded to develop transformative therapies for patients who currently depend on insulin injections.
Semma Therapeutics was founded to develop transformative therapies for patients who currently depend on insulin injections.
20
Country: France | Funding: €132.3M
Diabeloop is a medical device company for diabetes and closed-loop system.
Diabeloop is a medical device company for diabetes and closed-loop system.
